How has the understanding of gynecological cancers evolved?
The understanding of gynecological cancers has evolved significantly due to advancements in research and technology. The identification of molecular and genetic markers has led to improved diagnostic accuracy and personalized treatment approaches. For example, the discovery of specific genetic mutations, such as BRCA1 and BRCA2, has enabled targeted therapies for ovarian and breast cancers. Additionally, advancements in immunotherapy and targeted therapy have provided new treatment options for patients with advanced or resistant cancers. These breakthroughs have improved survival rates and quality of life for many patients.
